Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


  1. Published

    Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14)

    Bahlis, N. J., Baz, R., Harrison, S. J., Quach, H., Ho, S. J., Vangsted, Annette Juul, Plesner, T., Moreau, P., Gibbs, S. D., Coppola, S., Yang, X., Al Masud, A., Ross, J. A., Bueno, O. & Kaufman, J. L., 2021, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39, 32, p. 3602-3612

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients

    Højholt, K. L., Gregersen, H., Szabo, A. G., Klausen, T. W., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Iversen, K. F., Teodorescu, E. M., Kurt, E., Strandholdt, C., Andersen, M. K. & Vangsted, Annette Juul, 2021, In: Hematological Oncology. 39, 4, p. 521-528

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival

    Melaiu, O., Macauda, A., Sainz, J., Calvetti, D., Facioni, M. S., Maccari, G., ter Horst, R., Netea, M. G., Li, Y., Grząśko, N., Moreno, V., Jurczyszyn, A., Jerez, A., Watek, M., Varkonyi, J., Garcia-Sanz, R., Kruszewski, M., Dudziński, M., Kadar, K., Jacobsen, S. E. H. & 34 others, Mazur, G., Andersen, V., Rybicka, M., Zawirska, D., Raźny, M., Zaucha, J. M., Ostrovsky, O., Iskierka-Jazdzewska, E., Reis, R. M., Stępień, A., Beider, K., Nagler, A., Druzd-Sitek, A., Marques, H., Martìnez-Lopez, J., Lesueur, F., Avet-Loiseau, H., Vangsted, Annette Juul, Krawczyk-Kulis, M., Butrym, A., Jamroziak, K., Dumontet, C., Vogel, U., Rymko, M., Pelosini, M., Subocz, E., Szombath, G., Sarasquete, M. E., Silvestri, R., Morani, F., Landi, S., Campa, D., Canzian, F. & Gemignani, F., 15 Apr 2021, In: International Journal of Cancer. 148, 8, p. 1887-1894 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde

    Musto, P., Engelhardt, M., Caers, J., Bolli, N., Kaiser, M., van de Donk, N., Terpos, E., Broijl, A., de Larrea, C. F., Gay, F., Goldschmidt, H., Hajek, R., Vangsted, A. J., Zamagni, E., Zweegman, S., Cavo, M., Dimopoulos, M., Einsele, H., Ludwig, H., Barosi, G. & 4 others, Boccadoro, M., Mateos, M. V., Sonneveld, P. & Miguel, J. S., 2021, In: Haematologica. 106, 11, p. 2799-2812

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry

    Redder, L., Klausen, T. W., Vangsted, Annette Juul, Gregersen, H., Andersen, N. F., Pedersen, R. S., Szabo, A. G., Frederiksen, M., Frølund, U. C., Helleberg, C., Nielsen, L. K., Pedersen, P. T., Salomo, M., Gimsing, P., Frederiksen, H. & Abildgaard, N., 2021, In: British Journal of Haematology. 193, 1, p. 119-124 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio

    Szabo, A. G., Klausen, T. W., Abildgaard, N., Gregersen, H., Silkjær, T., Pedersen, P. T., Pedersen, R. S., Helleberg, C., Hermansen, E., Schnack, B. I. & Vangsted, Annette Juul, 2021, In: Blood Cancer Journal. 11, 4, 70.

    Research output: Contribution to journalLetterResearchpeer-review

  7. Published

    The real-world outcomes of multiple myeloma patients treated with daratumumab

    Szabo, A. G., Klausen, T. W., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Iversen, K. F., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C., Andersen, M. K. & Vangsted, Annette Juul, 2021, In: Plos One. 16, 10 October, p. 1-11 e0258487.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 9762536